tsoc tsoc annual...- 3 - 5ꓫ23ꓩꅱ걐듁꒻ꅲ08:45-10:15 saturday, may 23, 2015...

- 1 -

5月22日〈星期五〉16:20-18:30 FRIDAY, MAY 22, 2015

台北君悅酒店君寓一 Residence One, Grand Hyatt Taipei

CROSS-STRAIT FORUM ON CAD REVASCULARIZATION: MY BEST PCI CASE

16:20 Opening Remarks………..……………………………………..………………..………常敏之(Min-Ji Charng)

Chairs: 常敏之 (Min-Ji Charng)、謝宜璋 (I-Chang Hsieh)、

陳紹良 (Shao-Liang Chen)、陳良龍 (Liang-Long Chen)

Panels: 李文領 (Wen-Lieng Lee)、唐熠達 (Yida Tang)、林文華、

李敬田 (Jingtian Li)、董希昌 (Xichang Dong)、董　哲

16:25 Case 01: Reverse Wiring Could be Very Ddifficult for Bifurcation Lesion withStenoses in the Main Vessel both Proximal and Distal to the Bifurcation..……..李文領

(Wen-Lieng Lee)

16:40 Case 02…………………………….………………………….……….………………….葉　飛(Fei Ye)

16:55 Case 03: Successful IVUS-guided Recanalization of a LAD CTO LesionWe Failed for 3 Times Before…………………………………………………….…….盧澤民

(Tse-Min Lu)

17:10 Case 04…………………………….………………………….……….………………….王　焱(Yan Wang)

17:25 Case 05…………………………….………………………….……….………………….王志鴻(Ji-Hung Wang)

17:40 Case 06: 右位心患者冠脈介入治療……………………………………………..李敬田(Jingtian Li)

17:55 Case 07: IVUS Guided PCI for LAD CTO Lesion……….……….………………….謝宜璋(I-Chang Hsieh)

18:10 Case 08: 前三叉的介入治療……………………………………………………..鹿慶華(Ginghua Lu)

18:25 Closing Remarks………..……………………………………..………………..……….殷偉賢(Wei-Hsian Yin)

- 2 -

5月22日〈星期五〉18:30-20:30 FRIDAY, MAY 22, 2015

台北君悅酒店君寓一 Residence One, Grand Hyatt Taipei

SYMPOSIUM ON OPEN HEART SURGERY(ESPECIALLY NIGHTMARE EXPERIENCE)

開心手術(夢魘分享)

18:30 Opening Remarks………..………………………………………..………………..……王水深(Shoei-Shen Wang)

Chair: 李君儀 (Jiun-Yi Li)

18:35 Aortic Valve Reconstruction (AVP)..………..........….……………....……………….陶　凉

(Liang Tao)

Chair: 張重義 (Chung-I Chang)

19:00 Surgery for Young Marfan Syndrome Failed in Aortic Valve Repairand Small Annulus……………..………..........................................……………….陳益祥

(Yih-Sharng Chen)

Chair: 詹志洋 (Chih-Yang Chan)

19:15 Hybrid Surgery to Treat the Aortic Arch Diseases－12 Experences of the Single Center……..................................…………..………常光其

(Guangqi Chang)

Chair: 林萍章 (Pyng Jing Lin)

19:40 Iatrogenic Renal Trauma after Endovascular Aortic Aneurysm RepairMinimally Invasive Management with Microcatheter Embolization……………….吳毅暉

(I-Hui Wu)

Chair: 邱肇基 (Chaw-Chi Chiu)

19:55 Aortic Valve Reconstruction Using Autologous Pericardium forAortic Valve Deficiency……………………………………………………….…..Go Watanabe

(渡邊剛)

20:20 Closing Remarks…………………………….……………………......……………….張忠毅(Chung-Yi Chang)

- 3 -

5月23日〈星期六〉08:45-10:15 SATURDAY, MAY 23, 2015

台北國際會議中心(TICC) Room 102

JOINT COMMITTEE OF CRITICAL CARE MEDICINE CERTIFICATECOURSE ─ PERI-OPERATIVE CRITICAL MEDICAL ISSUES (I)

﹝REGISTRATION ONLY﹞

08:45 Opening Remarks...…..........................………………………………………………黃瑞仁(Juey-Jen Hwang)

Chair: 羅鴻舜 (Hung-Shun Lo)

08:55 Peri-Operative Risk Assessment for Non-Cardiac Surgery………....………….…趙安怡(Anne Chao)

Chair: 林昌琦 (Chang-Chyi Lin)

09:35 Pharmacology Bridging Issues of Anti-Thrombotic Agents, New & Old……….…邱俊仁(Chiung-Zuan Chiu)

- 4 -



JOINT COMMITTEE OF CRITICAL CARE MEDICINE CERTIFICATECOURSE ─ PERI-OPERATIVE CRITICAL MEDICAL ISSUES (II)

﹝REGISTRATION ONLY﹞

Chair: 潘如濱 (Ju-Pin Pan)

10:30 Management of Peri-Operative Hypertension……………………….…………….…黃啟祥(Chi-Hsiang Huang)

Chair: 陳文鍾 (Wen-Jone Chen)

11:10 Peri-Operativeβ-Blocker Administration, Friend or Foe?….…................….…..林宗憲(Tsung-Hsien Lin)

11:50 Closing Remarks…………………………..……..………………….……………..……曾稼志 (Chia-Chih Tseng Alex)

- 5 -



[ORAL PRESENTATION]BASIC SCIENCE (I)

Chairs: 吳茲睿 (Tsu-Juey Wu)、趙庭興 (Ting-Hsing Chao)、

李啟明 (Chii-Ming Lee)

08:45 Role of Sarcoplasmic Reticulum Calcium in Development ofSecondary Calcium Rise and Early Afterdepolarizationsin Long QT Syndrome Rabbit Model…...……………………………………………張伯丞

(Po-Cheng Chang)

09:00 Induced Pluripotent Stem Cells Alleviate Inflammation inMonocrotaline-induced Pulmonary Arterial Hypertension........……………………黃偉春

(Wei-Chun Huang)

09:15 Extracorporeal Shock Wave Effectively Attenuates Brain infarct Volumeand Improves Neurological Function in Rat after Acute Ischemic Stroke.………葉漢根

(Hon-Kan Yip)

09:30 Mechanistic Insights into Cardiac Conduction Disturbances inChronic Alcohol Ingestionl………………………………………………………………賴宇俊

(Yu-Jun Lai)

09:45 Exendin-4 Therapy Still Offered an Additional Benefit on ReducingTransverse Aortic Constriction-Induced Cardiac ypertrophy-CausedMyocardial Damage in DDP-4 Deficient Rats………………………………………吳勃銳

(Po-Jui Wu)

10:00 tPA-MMP-9 Axis Plays a Pivotal Role for Mobilization of EndothelialProgenitor Cells from Bone Marrow to Circulation andIschemic Region for Angiogenesis……………………………………………………呂史提

(Steve Len)

- 6 -



[ORAL PRESENTATION]BASIC SCIENCE (II)

Chairs: 陳偉踐 (Wei-Jan Chen)、王兆弘 (Chao-Hung Wang)、

李坤泰 (Kun-Tai Lee)

10:30 LQT-associated Genes in Patients with Congenital Long QTSyndrome in Taiwan……………………….…………………………………………….莊志明

(Jyh-Ming Juang)

10:45 Exploration of Aging-related microRNA in Angiogesis of Human EPCs………....蘇正煌(Cheng-Huang Su)

11:00 Unraveling Regulatory Mechanisms of Atrial Remodeling ofMitral Regurgitation Pigs by Gene Expression Profiling Analysis:Role of Type I Angiotensin II Receptor Antagoniste………………………………..陳勉成

(Mien-Cheng Chen)

11:15 Combined Therapy with Shock Wave and Autologous Bone Marrow-DerivedMesenchymal Stem Cells Alleviates Left Ventricular Dysfunction andRemodeling through Inhibiting Inflammatory Stimuli, Oxidative Stress &Enhancing Angiogenesis in a Swine Myocardial Infarction Model………………..黃田宏

(Tein-Hung Huang)

11:30 Intermittent Hypoxia Inhibits Intracellular pH Recovery fromAcidosis via Na+ Accumulation in Cardiomyocytes…………………………………張懷仁

(Huai-Ren Chang)

11:45 Benefit of Antioxidant Peptide SS-31 Treatment in Attenuating TransverseAortic Constriction-Induced Pulmonary Arterial Hypertension in Mice…………李芳艷

(Fan-Yen Lee)

- 7 -



[ORAL PRESENTATION]HEART FAILURE & HYPERTENSION

Chairs: 褚柏顯 (Pao-Hsien Chu)、駱惠銘 (Huey-Ming Lo)、

顏學偉 (Hsueh-Wei Yen)

08:45 Predictive Utility of B-Type Natruretic Peptide and Aquaporin-2 inPatients with Acute Decompensated Heart Failure Developingin-Hospital Acute Kidney Injury…………………………………………………………楊嘉浤

(Chia-Hung,Yang)

09:00 The Distinguished Impacts of Wave Reflection and ArterialStiffness on Clinical Outcomes of Acute Heart Failure……………………………宋思賢

(Shih-Hsien Sung)

09:15 Effect of Multidisciplinary Disease Management in Acute HeartFailure Patients Risk-stratified by Galectin-3 Levels......…………………..…….王兆弘

(Chao-Hung Wang)

09:30 Increased Galectin-3 was Closely Associated withArterial Wave Reflections and Provide Incremental PrognosticValue Upon Natriuretic Peptide……………………………………………...…………張俊欽

(Chun-Chin Chang)

09:45 Prognostic Value of Left Atrial Deformation in Hypertension………………………楊荔丹(Li-Tan Yang)

10:00 Severe Hyponatremia and In-Hospital Deterioration ofSodium is Associated with Increased Mortality inPatients Admitted with Acute Heart Failure………………………………….……….呂岱穎

(Dai-Yin Lu)

- 8 -



[ORAL PRESENTATION]CAD & ELECTROPHYSIOLOGY & CARDIAC IMAGING

Chairs: 洪志凌 (Chi-Ling Hang)、王俊傑 (Chun-Chieh Wang)、

梁馨月 (Hsin-Yueh Liang)

10:30 The Successful Experience of Establishment of Pre-Hospital ECGin Kaohsiung City…………………………………………………………………………洪正中

(Cheng-Chung Hung)

10:45 Clinical Outcomes of Drug-Eluting Stents Versus Bare-Metal Stentsin Acute Myocardial Infarction Patients under Hemodialysis………………………陳東藝

(Dong-Yi Chen)

11:00 Efficacy of Antiplatelet Agent Usage for Cardiovascular Outcome inDialysis Patients: A Nation-wide Data Survey and Propensity Analysis…………吳學明

(Wu Xue-Ming)

11:15 Impact of Renal Insufficiency on Clinical and AngiographicOutcomes Following Percutaneous Coronary Intervention withDrug-eluting Stents: Does the K/DOQI Classification Matter?……………………方慶章

(Ching-Chang Fang)

11:30 Bundled Preparation of Skin Antisepsis Decreases the Risk ofCardiac Implantable Electronic Device-Related Infection………………………….陳煌中

(Huang-Chung Chen)

11:45 The Impact of Age- and Gender-related Differences onLeft Ventricular Mechanics and Geometry in AsymptomaticPopulation: Special Focus on Torsion ………………………………………………宋國慈

(Kuo-Tzu Sung)

- 9 -


台北國際會議中心(TICC) 3F, South Foyer

[ORAL PRESENTATION]GENERAL CARDIOLOGY (I)

Chairs: 林明正 (Ming-Cheng Lin)、鄭正一 (Cheng-I Cheng)、

林亮宇 (Lian-Yu Lin)

08:45 Central Aortic Reservoir-Wave Analysis Predicted 20-Year All-Cause andCardiovascular Mortalities Independently of Wave Reflection andArterial Stiffness: A Community-Based Study………………………………………鄭浩民

(Hao-Min Cheng)

09:00 Outcomes of Endovascular Therapy in Consecutive 1000 Legs:Ten-Year Experiences from Single Center Hospital………………………………...黃玄禮

(Hsuan-Li Huang)

09:15 Combined Biomarker Analysis for Risk of Acute Kidney Injury inPatients with ST-Segment Elevation Myocardial Infarction………………………董穎璋

(Ying-Chang Tung)

09:30 The Synchronous Telehealth Service May Improve the Blood PressureManagement in Hypertensive Patient with Cardiovascular Diseases.(TELEHEALTH Study Group)…………………………………………………………陳盈憲

(Ying-Hsien Chen)

09:45 Increased Circulating Visfatin is Associated with Progression ofKidney Disease in Non-diabetic Hypertensive Patients…………………………….徐千彝

(Chien-Yi Hsu)

10:00 Osteoporosis Increases the Incidence of Heart Failure inTaiwanese Adults: Data from the National Health InsuranceResearch Database (NHIRD) in Taiwan………………………………………………邱俊仁

(Chiung-Zuan Chiu)

- 10 -



[ORAL PRESENTATION]GENERAL CARDIOLOGY (II) & PEDIATRIC CARDIOLOGY &

CARDIOVASCULAR SURGERY

Chairs: 王主科 (Jou-Kou Wang)、張仁平 (Jen-Ping Chang)、

陳志成 (Zhih-Cherng Chen)

10:30 Long-term Outcome of Patients with Giant Coronary AneurysmsCaused by Kawasaki Disease: A 30-year Experiencein a Single Center in Taiwan……………………………………………………………池宛玲

(Jyh-Ming Juang)

10:45 Comparative Analysis of Morphology of Ductus Arteriosus inDuctal Dependent Congenital Heart Diseases versus IsolatedPatent Ductus Arteriosus………………………………………………………………..林宜君

(I-Chun Lin)

11:00 Real Fime 3-dimensional Transesophageal EchocardiographicGuidance of Transcatheter Closure of Perimembranousand Muscular Ventricular Septal Defect………………………………………………謝凱生

(Kai-Sheng Hsieh)

11:15 The Efficacy and Safety of Amplatzer Duct Occluder inTranscatheter Closure of Perimembranous VentricularSeptal Defects: Short-term Results.…………………………………………………陳豐霖

(Fong-Lin Chen)

11:30 Perioperative Management of Patients Enrolled in TAVI Program-Early Experience of KMUH……………………………………………………………唐貞綾

(Chen-Ling Tang)

11:45 Erythropoietin Improves Long-Term Neurological Outcome inAcute Ischemic Stroke Patients: A Randomized, Prospective,Placebo-Controlled Clinical Trial……………………………………………………….蔡子賢

(Tzu-Hsien Tsai)

- 11 -


台北國際會議中心(TICC) Room 201DE

ESC*-TSOC JOINT SESSION (I)Frequent Problems In Cardiology: The European And Taiwanese Perspective

Atrial Fibrillation

08:45 Opening Remarks……………………………………………….……….………..……..葉森洲(San-Jou Yeh)

Chair: 陳志鴻 (Jyh-Hong Chen)

08:50 Guidelines and Controversies in Europe……………………………....……Gregory YH Lip

09:25 Q & A

Chair: 林幸榮 (Shing-Jong Lin)

09:35 What is Different from Europe and What is the State of the Art?..……..………...江晨恩(Chern-En Chiang)

10:10 Q & A

*European Society of Cardiology

- 12 -



ESC*-TSOC JOINT SESSION (II)

Acute Coronary Syndromes

Chair: 江福田 (Fu-Tien Chiang)

10:30 Guidelines and Controversies in Europe..……………………………………Adnan Kastrati

11:05 Q & A

Chair: 謝士明 (Shyh-Ming Shieh)

11:15 What is Different from Europe and What is the State of the Art?.......................褚柏顯(Pao-Hsien Chu)

11:50 Q & A

11:55 Closing Remarks……………………………………………….….…….………..……..陳肇文(Jaw-Wen Chen)

*European Society of Cardiology

- 13 -


台北國際會議中心(TICC) Room 201F

APSC*-TSOC JOINT SESSION

08:45 Opening Remarks……………………………………………….……….………..……..江正文(Cheng-Wen Chiang)

Chair: 江正文 (Cheng-Wen Chiang)

08:50 Clinical Application of Human iPS Cells for Cardiovascular Medicine…..Keiichi Fukuda

Chair: 張茂松 (Mau-Song Chang)

09:20 Human Placenta-Derived Multipotent Cells Modulate Cardiac Injury.……………劉芫宏(Yuan-Hung Liu)

Chair: 蔡建松 (Chien-Sung Tsai)

09:40 Interventional Cardiology in the 21st Century:A Surgeon's Perspective……………….……………………………..Kenny Yoong-Kong Sin

10:10 Closing Remarks……………………………………………….……………..………….蔡正河(Cheng-Ho Tsai)

*Asian Pacific Society of Cardiology

- 14 -



KSC*-TSOC JOINT SESSION

10:30 Opening Remarks…..……………….……..……………………………………….....呂鴻基(Hung-Chi Lue)

Chair: 呂鴻基 (Hung-Chi Lue)

10:35 Secondary Mitral Regurgitation Caused by Ischemic orDilated Cardiomyopathy………………………………………………………...Jong-Min Song

11:05 Q & A

Chair: 林芬瓊 (Fen-Chiung Lin)

11:15 The Next Step after Digital Echocardiography and Wireless Medicine……..……林隆君(Lung-Chun Lin)

11:45 Q & A

11:55 Closing Remarks……………………………………..………………………..…………李源德(Yuan-Teh Lee)

*Korean Society of Cardiology

- 15 -


台北國際會議中心(TICC) Room 201A

TSOC YOUNG INVESTIGATORS AWARDFINALISTS PRESENTATION

Referees: 林俊立 (Jiunn-Lee Lin)、林芬瓊 (Fen-Chiung Lin)、

柯毓麟 (Yu-Lin Ko)、陳勉成 (Mien-Cheng Chen)、

蘇正煌 (Cheng-Huang Su)

08:45 The Molecular Mechanisms Responsible for Galectin-3-mediated CardiacFibrosis in Pressure-overload Mouse Model: in-vitro and in-vivo Studies….……郝文瑞

(Wen-Rui Hao)

09:00 Arachidonate 12/15-lipoxygenase as Progression Marker in Patient-specificInduced Pluripotent Stem Cells and Fabry Cardiomyopathy………………………呂岱穎

(Dai-Yin Lu)

09:15 Discrepant Fibroblast Activity in the Left and Right Atrium throughDifferent Stress-induced Mitogen-activated Protein Kinase Signaling…………鍾承志

(Cheng-Chih Chung)

09:30 Advanced Renal Failure Enhances Genesis of Atrial Arrhythmia with IncreasedArrhythmogenesis of Pulmonary Veins, Atrium and Sinoatrial Node……………黄奭毓

(Shih-Yu Huang)

09:45 Is There a Different Age Threshold for Increased Stroke Risk AmongstAsian Patients with Atrial Fibrillation? A Nationwide Cohort Study………………趙子凡

(Tze-Fan Chao)

- 16 -



INTERNATIONAL YOUNG INVESTIGATORS AWARD PRESENTATION

10:30 Introduction………………….……………….……………………………………………賴文德(Wen-Ter Lai)

Chair: 陳益祥 (Yih-Sharng Chen)

10:35 Constructing Novel Therapeutic Strategy withVentricular Assist Device in Japan………………………………………..Teruhiko Imamura

Chair: 陳雲亮 (Wan-Leong Chan)

10:57 Intracoronary Dual-modal OCT-NIRF Structural-Molecular Imaging withApproved Indocyanine Green (ICG) to Assess High-risk CoronaryAtheromata and Drug-eluting Stent (DES)-related Inflammation inA Beating Swine Heart…………….………………………………………………Sunwon Kim

Chair: TBA

11:19 TBA.…...………..………………………………………………………………………………TBA

Chair: 傅懋洋 (Morgan Mao-Young Fu)

11:41 Clinical and Genetic Predictors of the Blood Pressure Response and AdverseSide Effects to Thiazide Diuretics in Hypertensive Patients in Taiwan….……….黃金洲

(Chin-Chou Huang)

- 17 -



THS*-TSOC JOINT SYMPOSIUM (I):HT GUIDELINES: WHEN EAST MEETS WEST?

14:00 Opening Remarks...…......................................………………………..……………曾淵如(Yung-Zu Tseng)

Chair: 江福田 (Fu-Tien Chiang)

14:05 2014 HT Guidelines of ASH/ISH……………...……………………………..William B. White


14:40 2015 HT Guidelines of TSOC/TSH……………….…………………………….……..江晨恩(Chern-En Chiang)


15:15 Panel Discussion

15:25 Closing Remarks…………………………..……..…………………………….…….….陳志鴻 (Jyh-Hong Chen)

*Taiwan Hypertension Society

- 18 -



THS*-TSOC JOINT SYMPOSIUM (II):WHAT’S HOT IN 2015?

15:45 Opening Remarks...…........................………………………………………………陳文鍾(Wen-Jone Chen)

Chair: 陳文鍾 (Wen-Jone Chen)

15:50 150/90 or 140/90 mmHg for Elderly Patients with Hypertension:Updated Evidence and Precautions….……..……......................................……..葉宏一

(Hung-I Yeh)

Chair: 賴文德 (Wen-Ter Lai)

16:10 130/80 or 140/90 for Patients with Hypertension and Stroke:Updated Evidence and Precautions.............................................................…..林宗憲

(Tsung-Hsien Lin)

Chair: 賴文德 (Wen-Ter Lai)

16:30 Renal Denervation in 2015: Lessons Learned, New Insights,and Ways Forward.....................…….......................………..............Markus P. Schlaich

Chair: 李貽恆 (Yi-Heng Li)


17:10 Closing Remarks…………………………..……..………………………….…….…...李貽恆(Yi-Heng Li)

*Taiwan Hypertension Society

- 19 -



SYMPOSIUM ON HEART FAILURE (I):FROM BENCH TO BEDSIDE

14:00 Opening Remarks…………………………………………..…………………………….徐國基(Kou-Gi Shyu)

Chair: 王俊傑 (Chun-Chieh Wang)

14:05 cGMP Signaling Pathway and Cardiac Patho-Physiology………….…….....Eiki Takimoto

Chair: 鄭景仁 (Jing-Ren Jeng)

14:30 Novel Biomarkers in Heart Failure..………………...…………………....................楊鎧鍵(Kai-Chien Yang)

Chair: 林維祥 (Wei-Shiang Lin)

14:55 How to Use Biomarkers for the Diagnosis, Prognostication andManagement of Heart Failure Patients……………………...………......................褚柏顯

(Pao-Hsien Chu)

Chair: 洪大川 (Ta-Chuan Hung)

15:20 Discussion

15:30 Closing Remarks…………………………………………………………….……………顏學偉(Hsueh-Wei Yen)

- 20 -



SYMPOSIUM ON HEART FAILURE (II):NEW FRONTIERS OF HEART FAILURE TREATMENT

15:40 Opening Remarks………..……………………………………..………………..………張坤正(Kuan-Cheng Chang)

Chair: 黃金隆 (Jin-Long Huang)

15:45 The Funny Current: Cellular Basis and Clinical Application………………………江晨恩(Chern-En Chiang)

Chair: 吳彥雯 (Yen-Wen Wu)

16:10 Angiotensin-neprilysin Inhibition for Heart Failure…………………………………..張鴻猷(Hung-Yu Chang)

Chair: 柯文欽 (Wen-Chin Ko)

16:35 Stem Cells and Regenerative Medicine for Heart Failure…………………………黃柏勳(Po-Hsun Huang)

Chair: 王兆弘 (Chao-Hung Wang)

17:00 Discussion

17:10 Closing Remarks………..……………………………………..………………..……….殷偉賢(Wei-Hsian Yin)

- 21 -



SYMPOSIUM ON LEGAL ISSUES OFCARDIOVASCULAR MANAGEMENT

心臟病人的醫療糾紛

Chairs: 王水深 (Shoei-Shen Wang)、蔡建松 (Chien-Sung Tsai)

14:00 TBA................................................………...………………………………………..何祖舜()

14:30 由“經皮冠狀動脈氣球成形術”

之醫療糾紛案談醫療水準與醫療常規…………………………………………王聖惠(Sheng-Huey Wang)

15:00 台灣醫療訴訟之改進：以日本為鏡...............................................….……林萍章(Pyng Jing Lin)

- 22 -



TSPC*-TSOC JOINT SYMPOSIUM ON VSD OCCLUDER﹝REGISTRATION ONLY﹞

Chairs: 張重義 (Chung-I Chang)、黃碧桃 (Be-Tau Hwang)

15:45 Anatomy and Classification of VSD-Association with Conduction System………潘俊彥(Jun-Yen Pan)

15:55 Tips & Tricks of Perimembranous VSD Transcatheter Closure...........………...王主科(Jou-Kou Wang)

16:10 Complications & Outcomes of Transcatheter Closure…………........……………..傅雲慶(Yun-Ching Fu)

16:25 Transesophageal Echocardiographic Monitoring for PercutaneousVentricular Septal Defect Closure..................................…..............….………...許瑞育

(Jui-Yu Hsu)

16:40 Choice of Devices in Transcatheter VSD Closure...…..……….........….……..…..王玠能(Jieh-Neng Wang)

16:50 Hybrid Procedure for Ventricular Septal Defect Closure...............…….………...陳益祥(Yih-Sharng Chen)

17:05 Panel Discussion………………..……………..………………………..….……..……………AII

*Taiwan Society of Pediatric Cardiology

- 23 -



SYMPOSIUM ON EVALUATION & MANAGEMENT OF SYNCOPE

14:00 Opening & Introduction..……………………………………..………………..………..郭任遠(Jen-Yuan Kuo)

Chair: 郭任遠 (Jen-Yuan Kuo)

14:05 Classification, Epidemiology & Prognosis of Syncope……………………………...李坤泰(Kun-Tai Lee)

Chair: 柯文欽 (Wen-Chin Ko)

14:20 Initial Evaluation & Diagnosis of Syncope…………………………………………….張伯丞(Po-Cheng Chang)

14:35 Risk Stratification of Syncope: When Should Patients be Admitted?…………….謝育整(Yu-Cheng Hsieh)

Chair: 侯嘉殷 (Charles Jia-Yin Hou)

14:50 Treatment of Reflex Syncope & Orthostatic Intolerance Syndrome………………陳儒逸(Ju-Yi Chen)

15:05 Treatment of Syncope in Patients with High Risk of Sudden Death……………...馮安寧(An-Ning Feng)

Chair: 溫明賢 (Ming-Shien Wen)


- 24 -



THRS*-TSOC JOINT SYMPOSIUM:HOT TOPICS IN ATRIAL FIBRILLATION

Chair: 陳適安 (Shih-Ann Chen)

15:45 Anticoagulation Therapy in Heart Failure Patientswith Atrial Fibrillation……………………………………………………………Gregory YH Lip

Chair: 葉冠宏 (Kuan-Hung Yeh)

16:15 Anticoagulation Therapy in CAD Patients with Atrial Fibrillation…………………李貽恆(Yi-Heng Li)

Chair: 邱春旺 (Chuen-Wang Chiou)

16:35 What’s New in Catheter Ablation of Atrial Fibrillation?…………………………….林彥璋(Yenn-Jiang Lin)

16:55 What’s New in Rhythm vs. Rate Control of Atrial Fibrillation?……………………王俊傑(Chun-Chieh Wang)

*Taiwan Heart Rhythm Society

- 25 -



ACC* IN TAIWAN SESSION (I):NEW BREAKTHROUGH IN CORONARY ARTERY DISEASE

14:00 Opening Remarks………………………………………….…….….………..………….林幸榮(Shing-Jong Lin)

Chair: 洪瑞松 (Jui-Sung Hung)

14:05 Clinical Implications of the Dual Antiplatelet Therapy Trial…….……..Ehtisham Mahmud

14:40 Q & A

Chair: 曾春典 (Chuen-Den Tseng)

14:50 Local Management of ACS Patients in Taiwan………………………..……………鄭正一(Cheng-I Cheng)

15:25 Q & A

*American College of Cardiology

- 26 -



ACC* IN TAIWAN SESSION (II):NEW BREAKTHROUGH IN TRANSCATHETER VALVULAR

THERAPEUTICS

Chair: 程俊傑 (Jun-Jack Cheng)

15:45 Breakthroughs in Transcatheter Valvular Therapeutics……..………..…..E. Murat Tuzcu

16:20 Q & A

Chair: 黃瑞仁 (Juey-Jen Hwang)

16:30 Current Status of TAVI in Taiwan………………………....……………………….….陳嬰華(Ying-Hwa Chen)

17:05 Q & A

17:10 Closing Remarks….……………………………………….….…….………..………….常敏之(Min-Ji Charng)

*American College of Cardiology

- 27 -



JCS*-TSOC JOINT SESSION:ARRHYTHMIAS IN STRUCTURAL HEART DISEASE

14:00 Opening Remarks…..……………….……..……………………………………….…...黃水坤(Shoei K. Stephen Huang)

Chair: 黃水坤 (Shoei K. Stephen Huang)

14:05 Radiofrequency Catheter Ablation of Ventricular Tachycardia inStructural Heart Disease: A Comprehensive Review in the Era ofSubstrate-Based Ablation………………………………………………………….Hiroshi Tada

Chair: 蔡佳醍 (Chia-Ti Tsai)

14:30 The Role of Common and Rare Genetic Variants Implicated inSusceptibility to Atrial Fibrillation.……………………………………..…..…Kenshi Hayashi

Chair: 溫明賢 (Ming-Shien Wen)

14:55 Magnetic Resonance Imaging Defined Substrate Predisposing toVentricular Tachyarrhythmias in Ischemic Heart Diseasewith Heart Failure…………………………………………………………………………林亮宇

(Lian-Yu Lin)

15:20 Closing Remarks……………………………………..………………………..…………溫明賢(Ming-Shien Wen)

*The Japanese Circulation Society

- 28 -



SYMPOSIUM ON UPDATED GUIDELINES FOR VALVULAR HEARTDISEASE ─ BASED ON 2014 AHA/ACC GUIDELINES

15:45 Opening Remarks………..……………………………………..………………..………蔡良敏(Liang-Miin Tsai)

Chair: 徐粹烈 (Tsui-Lieh Hsu)

15:50 General Principle…………………………………………………………………………洪國竣(Kuo-Chun Hung)

Chair: 許勝雄 (Sheng-Hsiung Sheu)

16:05 Aortic Stenosis……………………………………………………………………………林隆君(Lung-Chun Lin)

Chair: 傅懋洋 (Morgan Mao-Young Fu)

16:20 Aortic Regurgitation………………………………………………………………………秦志輝(Chih-Hui Chin)


16:35 Mitral Stenosis…………………………………………………………………………….梁馨月(Hsin-Yueh Liang)

Chair: 周湘台 (Hsiang-Tai Chou)

16:50 Mitral Regurgitation………………………………………………………………………李道輿(Tao-Yu Lee)

17:05 Closing Remarks…………………………….………………………….……….……….林芬瓊(Fen-Chiung Lin)

- 29 -



SYMPOSIUM ON BASIC RESEARCH IN ATRIAL FIBRILLATION

14:00 Opening Remarks………..……………………………………..………………..………江晨恩(Chern-En Chiang)

Chair: 林俊立 (Jiunn-Lee Lin)

14:05 Genetic Determinants of AF……………………………………………………………蔡佳醍(Chia-Ti Tsai)

Chair: 吳茲睿 (Tsu-Juey Wu)

14:25 Signal Transduction in AF………………………………………………………………葉勇信(Yung-Hsin Yeh)

Chair: 陳亦仁 (Yi-Jen Chen)

14:45 Cellular Mechanism of AF……………………………………………………………….張世霖(Shih-Lin Chang)

Chair: 張坤正 (Kuan-Cheng Chang)


15:15 Closing Remarks………..……………………………………..……………....……...…林俊立 (Jiunn-Lee Lin)

- 30 -

�\



SYMPOSIUM ON RECENT ADVANCE IN VASCULARBIOAVAILABILITY

15:45 Opening Remarks………..……………………………………..………………..………陳明豐(Ming-Fong Chen)

Chair: 陳明豐 (Ming-Fong Chen)

15:50 From Lipids Go Glycans, and Vice Versa……………………………………………陳珠璜(Chu-Huang Chen)

Chair: 徐國基 (Kou-Gi Shyu)

16:15 The Role of Microparticles in Angiogenesis…………………………………………葉漢根(Hon-Kan Yip)

Chair: 葉宏一 (Hung-I Yeh)

16:35 From Vascular to Myocardium: Role of Electronegative LDL……………………張坤正(Kuan-Cheng Chang)

Chair: 姜必寧 (Benjamin N. Chiang)

16:55 The Genetic Basis for Atherosclerosis Diseases…………………………………….凃　欣(Xin Tu)

17:25 Closing Remarks………..………………….…………………..………………..………陳肇文(Jaw-Wen Chen)

- 31 -


Demo：Taichung Veterans General Hospital,Taichung

Lecture：Room 201BC, TICC,Taipei

LIVE DEMONSTRATION

08:25 Opening Remarks………………………………………………………………………葉森洲(San-Jou Yeh)

08:35 Session IOperators : (Rm. I) TBA

(Rm. II) Emmanouil S. Brilakis(Rm. III) 張其任 (Chi-Jen Chang)

IVUS, OCT, FFR Experts: 顧博明 (Po-Ming Ku)、黃慶昌 (Ching-Chang Huang)

Chairs : 黃瑞仁 (Juey-Jen Hwang)、常敏之 (Min-Ji Charng)、

陳紹良 (Shao-Liang Chen)、Toshiya Muramatsu

Commentators : 任勗龍 (Hsu-Lung Jen)、黃啟宏 (Chi-Hung Huang)、

林宗憲 (Tsung-Hsien Lin)、劉世奇 (Shih-Chi Liu)、

劉紅旭、葉　飛 (Fei Ye)、李忠祐 (Chongyou Lee)、

許榮城 (Jung-Cheng Hsu)

09:15-09:25 Lecture 1: What’s the Optimal PCI Strategy to CTO?..………….Toshiya Muramatsu

10:30 Session IIOperators : (Rm. I) 王志鴻 (Ji-Hung Wang)、陳郁志 (Michael Yu-Chih Chen)

(Rm. II) Gerald S. Werner(Rm. III) Etsuo Tsuchikane

IVUS, OCT, FFR Experts: 顧博明 (Po-Ming Ku)、黃慶昌 (Ching-Chang Huang)

Chairs : 程俊傑 (Jun-Jack Cheng)、Eisho Kyo、E. Murat Tuzcu、

Yang-Soo Jang

Commentators : 陳良龍 (Liang-Long Chen)、柯毓麟 (Yu-Lin Ko)、

王　焱 (Yan Wang)、方慶章 (Ching-Chang Fang)、

羅秉漢 (Ping-Han Lo)、葉漢根 (Hon-Kan Yip)、

郭風裕 (Feng-Yu Kuo)、吳孟修 (Menghsiu Wu)

11:00-11:10 Lecture 2: Role of IVUS in CTO PCI…………………………………….Yang-Soo Jang

12:00 Lunch Time

- 32 -


Demo：Taichung Veterans General Hospital, Taichung

Lecture：Room 201BC, TICC,Taipei

LIVE DEMONSTRATION

13:30 Session IIIOperators : (Rm. I) Praveen Chandra

(Rm. II) Jae-Kyu Kim(Rm. III) 潘　威 (Uei Pua)

IVUS, OCT, FFR Experts: 廖智冠 (Chih-Kuan Liao)、林佳濱 (Chia-Pin Lin)

Chairs : 殷偉賢 (Wei-Hsian Yin)、Emmanouil S. Brilakis、

洪志凌 (Chi-Ling Hang)、黄玄禮 (Hsuan-Li Huang)

Commentators : Kiyonori Nanto、Yoshimitsu Soga、陳志成 (Zhih-Cherng Chen)、

施俊明 (Chun-Ming Shih)、曾維功 (Wei-Kung Tseng)、

盧長林 (Changlin Lu)、徐中和 (Chung-Ho Hsu)

14:20-14:30 Lecture 3: What is Optimal Treatment Strategy for SFA Lesion?…...Kiyonori Nanto

14:50-15:00 Lecture 4: Management of LM Bifurcation Lesions……………Emmanouil S. Brilakis

15:30 Session IVOperators : (Rm. I) Toshiya Muramatsu(Rm. II) Proctored Cases: 陳俊吉 (Chen-Chun-Chi)、謝宜璋 (I-Chang Hsieh)(Rm. III) Proctored Cases: 宋思賢 (Shih-Hsien Sung)、盧澤民 (Tse-Min Lu)

IVUS, OCT, FFR Experts: 廖智冠 (Chih-Kuan Liao)、林佳濱 (Chia-Pin Lin)

Chairs : 吳炯仁 (Chiung-Jen Wu)、高憲立 (Hsien-Li Kao)、Hyo-Soo Kim、Gerald S. Werner 、Etsuo Tsuchikane、

Commentators : 曹殿萍 (Tien-Ping Tsao)、張恒嘉 (Heng-Chia Chang)、陳清埤 (Ching-Pei Chen)、陳逸忠 (I-Chung Chen)、邱俊仁 (Chiung-Zuan Chiu)、蔡政廷 (Cheng-Ting Tsai)、駱志剛 (Zhigang Luo)

16:20-16:30 Lecture 5: Use of Multislice CT to Assist CTO PCI…………………Gerald S. Werner

16:50-17:00 Lecture 6: Peripheral Intervention for CTO Lesions…………………Yoshimitsu Soga

17:25 Closing Remarks………………………………………………………………………….李文領 (Wen-Lieng Lee)

- 33 -

5月24日〈星期日〉08:30-10:55 SUNDAY, MAY 24, 2015

台北國際會議中心(TICC) 3F, Banquet Hall

08:30 TSOC President Address……………………………………………………………...葉森洲(San-Jou Yeh)

YOUNG INVESTIGATOR AWARD LECTURE

Chair: 林俊立 (Jiunn-Lee Lin)

08:35 The Molecular Mechanisms Responsible for Galectin-3-mediatedCardiac Fibrosis in Pressure-overload Mouse Model:in-vitro and in-vivo Studies……………………………………………….................郝文瑞

(Wen-Rui Hao)

NONG TING AWARD LECTURE

Chair: 姜必寧 (Benjamin N. Chiang)

08:50 A Cardiologist's Adventure into the Brain and Mind………..……………………….高憲立(Hsien-Li Kao)

PLENARY SPEECHES

Chair: 江志桓 (Chi-Woon Kong)

09:10 Future of PAH Treatment….…………………..……….……………..Vallerie V. McLaughlin

Chair: 吳德朗 (Delon Wu)

09:40 Perspective on Cardiovascular Intervention………………..………….…Gerald S. Werner

TSOC GENERAL ASSEMBLY

10:20 TSOC General Assembly

Chairs: 葉森洲 (San-Jou Yeh) 理事長、蔡正河 (Cheng-Ho Tsai) 常務監事

Reporter: 葉宏一 (Hung-I Yeh) 秘書長

- 34 -

5月24日〈星期日〉11:00-12:30 SUNDAY, MAY 24, 2015


SYMPOSIUM ON HEALTHCARE QUALITY AND MEDICAL LAW

Chairs: 黃蓮奇 (Lien-Chi Huang)、侯嘉殷 (Charles Jia-Yin Hou)

11:00 Reducing Central Line Associated Bloodstream Infection (CLABSI) byCentral Venous Catheter (CVC) Care Bundle………………….…...........…....…..李聰明

(Chun Ming Lee)

11:40 Q & A

11:45 告知後同意的有效性與法律上的爭議…………………………….....……..王志嘉(Chih-Chia Wang)

12:25 Q & A

- 35 -

5月24日〈星期日〉11:00-12:30 SUNDAY, MAY 24, 2015


SYMPOSIUM ON CURRENT STATUS OFPULMONARY HYPERTENSION

11:00 Opening Remarks………..……………………………………..………………..………曾春典(Chuen-Den Tseng)

Chair: 曾春典 (Chuen-Den Tseng)

11:05 Treatment Goals and Follow-up Strategy of PAH…………………………….Olivier Sitbon

Chair: 許子秀 (Tsu-Shiu Hsu)

11:45 國內 PAH案例登錄研究……………………………………………………………王國陽(Kuo-Yang Wang)

Chair: 吳俊逸 (Chun-Yi Wu)

12:05 CTEPH 台灣 Surgical開刀現況……………………………………………………黃書健(Shu-Chien Huang)

12:25 Closing Remarks………..……………………………………..…….…………..………傅懋洋 (Morgan Mao-Young Fu)

- 36 -

5月24日〈星期日〉14:30-16:00 SUNDAY, MAY 24, 2015


TATCS*-TSVS*-TSOC JOINT SYMPOSIUM ONROBOTIC SURGERY

Chair: 楊友任 (Yu-Jen Yang)

14:30 Result of Robotic Assisted Mitral Valve Surgery……...…………………………..紀乃新(Nai-Hsin Chi)

Chair: 李芳艷 (Fan-Yen Lee)

14:50 Robotic Assisted Coronary Artery Bypass Grafting at Taichung VGH...........…..張　燕(Yen Chang)

Chair: 施俊哲 (Chun-Che Shih)

15:10 Robotically Assisted Arrythmia Surgery-Short Term Experience in Chi-Mei Medical Center-.................…....……..……..鄭伯智

(Bor-Chih Cheng)

Chair: 虞希禹 (Hsi-Yu Yu)

15:30 Total Video System.................................................…………...............….……..邱冠明(Kuan-Ming Chiu)

Chair: 蔡建松 (Chien-Sung Tsai)

15:50 Panel Discussion………………..…..……………..………………………..….………………AII

*Taiwan Association of Thoracic & Cardiovascular Surgery*Taiwan Society for Vascular Surgery

- 37 -

5月24日〈星期日〉11:00-12:30 SUNDAY, MAY 24, 2015


SYMPOSIUM ON UNDERSTANDING THE NEW TW-DRGS AND ICD-10FOR CARDIOLOGY

11:00 Opening Remarks………..……………………………………..………………..………雷孟桓(Meng-Huan Lei)

Chair: 徐迺維 (Nai-Wei Hsu)

11:05 The Impact of Second-stage TW-DRGs for the Medicare ofCardiovascular Disease…………………………………………………………………吳道正

(Tao-Cheng Wu)

11:40 Q & A

Chair: 林立人 (Li-Jen Lin)

11:45 The Impact of ICD-9 Coding Conversion to ICD-10 on CardiovascularService in Clinic and Hospital…………………………………………………………魏秀美

(Hsiu-Mei Wei)

12:20 Q & A

12:25 Closing Remarks………..……………………………………..………………..………王志鴻(Ji-Hung Wang)

- 38 -

5月24日〈星期日〉14:30-16:00 SUNDAY, MAY 24, 2015


TSPC*-TSOC JOINT SYMPOSIUM ONSUDDEN CARDIAC DEATH IN PEDIATRICS

Chairs: 蘇文鉁 (Wen-Jen Su)、陳銘仁 (Ming-Ren Chen)

14:30 Epidemiology and Etiology of Sudden Cardiac Death in GeneralPediatric Population.............................................................................…....…..吳美環

(Mei-Hwan Wu)

14:45 Sudden Cardiac Death in Congenital Heart Disease……….……….......….……..盧俊維(Chun-Wei Lu)

15:00 Screening of Sudden Cardiac Death in General Pediatric Population......……....李必昌(Pi-Chang Lee)

15:15 Primary Prevention in Pediatric Sudden Cardiac Death..……...............….……..邱舜南(Shuenn-Nan Chiu)

15:30 Secondary Prevention and Device Therapy in PediatricSudden Cardiac Death……..................................................................…....…..林明志

(Ming-Chih Lin)

15:45 Panel Discussion………………..……………..………………………..….…………………AII

*Taiwan Society of Pediatric Cardiology

- 39 -

5月24日〈星期日〉11:00-12:30 SUNDAY, MAY 24, 2015


SYMPOSIUM ON PREVENTIVE CARDIOLOGY(I):AIR POLLUTION AND CARDIOVASCULAR DISEASES

11:00 Opening Remarks..…....................…….......…………………………………………陳震寰(Chen-Huan Chen)

Chair: 陳震寰 (Chen-Huan Chen)

11:05 心臟血管疾病的氣候因素

Climate Factors for Cardiovascular Diseases……….……………………………....郭育良(Yue-Leon Guo)

Chair: 陳震寰 (Chen-Huan Chen)

11:25 空氣微粒的心臟毒性

Cardiovascular Toxicities of Ambient Particles..…………………….….….………..鄭尊仁(Tsun-Jjen Cheng)

Chair: 郭育良 (Yue-Leon Guo)

11:45 空氣汙染與心臟血管健康:台灣經驗Air Pollution and Cardiovascular Health in Taiwan………………………..………..詹長權

(Chang-Chuan Chan)

Chair: 郭育良 (Yue-Leon Guo)

12:05 空氣汙染與亞臨床心臟血管健康

Air Pollution and Subclinical Cardiovascular Health……………...……….………..蘇大成(Ta-Chen Su)

12:25 Closing Remarks…………………………..……..…………………………….………..詹長權(Chang-Chuan Chan)

- 40 -

5月24日〈星期日〉14:30-16:00 SUNDAY, MAY 24, 2015


SYMPOSIUM ON PREVENTIVE CARDIOLOGY(II):ENDOCRINE DISRUPTING CHEMICALS AND CARDIOVASCULAR

DISEASES

14:30 Opening Remarks..…............................……………………………………...………詹長權(Chang-Chuan Chan)

Chair: 詹長權 (Chang-Chuan Chan)

14:35 暴露全氟碳化合物與心臟血管健康

Exposure to Perfluoroalkyl Substances and Cardiovascular Health……..……….陳保中(Pau-Chung Chen)

Chair: 詹長權 (Chang-Chuan Chan)

14:55 塑化劑與心臟血管疾病

Phthalate Diesters and Cardiovascular Health….………………….………..………蘇大成(Ta-Chen Su)

Chair: 陳保中 (Pau-Chung Chen)

15:15 The Relationship Between Maternal Phthalate Exposure andChildhood Adipokine……………………………………………………………………..王淑麗

(Shu-Li Wang)

Chair: 陳保中 (Pau-Chung Chen)

15:35 塑化劑對脂肪細胞能量代謝之影響

Effect of Phthalates on Energy Metabolism in Fat Cells…….……………………..鄒粹軍(Tsui-Chun Tsou)

15:55 Closing Remarks………………………..……..……………………….……….…….…蘇大成(Ta-Chen Su)

- 41 -

5月24日〈星期日〉11:00-12:40 SUNDAY, MAY 24, 2015

台北國際會議中心 (TICC) Room 201BC

UPDATE IN CURRENT TREATMENTS:FROM THE MASTERS

11:00 Opening Remarks………..……………………………………..………………..………程俊傑(Jun-Jack Cheng)


11:05 Update of Antiplatelet Therapy in PCI…………………………………………………李貽恆(Yi-Heng Li)


11:23 Overview of BVS, Beyond DES………………………………………….Praveen Chandra


11:41 Mechanism and Solution of Paravalvular Leakage of TAVI………………….Hyo-Soo Kim

Chair: 李文領 (Wen-Lieng Lee)

11:59 Renal Denervation: Optimization of Procedural Aspects...............…Markus P. Schlaich

Chair: 翁國昌 (Kwo-Chang Ueng)

12:17 New Application of DEB in Coronary Intervention…………………………………謝宜璋(I-Chang Hsieh)

12:35 Closing Remarks…………………………….………………………….……….…….…廖朝崧(Chiau-Suong Liau)

- 42 -

5月24日〈星期日〉14:30-16:25 SUNDAY, MAY 24, 2015

台北國際會議中心 (TICC) Room 201BC

TSCI*-TSOC JOINT SYMPOSIUM ONCTO AND COMPLEX PCI 2015: WHEN EAST MEETS WEST

14:30 Opening Remarks………..……………………………………..………………..………黃瑞仁(Juey-Jen Hwang)

Chair: Hyo-Soo Kim

14:35 TSOC-TOPIC: New Devices & Techniques in Japan for CTO………Toshiya Muramatsu


14:53 TSOC-EuroPCR: The Continental Approach to CTO-PCI………………Gerald S. Werner

Chair: 陳雲亮 (Wan-Leong Chan)

15:11 TSOC-India: CTO Revascularizations in India……………………………Praveen Chandra

Chair: 王志鴻 (Ji-Hung Wang)

15:29 TSOC-USA: Progress CTO Registry………………………..………..Emmanouil S. Brilakis

Chair: 常敏之 (Min-Ji Charng)

15:47 TSOC-ENCORE Seoul: CTO PCI: Evidence from Korea Registryand Randomized Controlled Trials……………………………………………Yang-Soo Jang

Chair: 殷偉賢 (Wei-Hsian Yin)

16:05 TSOC-TSCI: Tips and Tricks of CTO Intervention: Taiwan Experiences………高憲立(Hsien-Li Kao)

16:23 Closing Remarks…………………………….………………………….……….………李文領(Wen-Lieng Lee)

*Taiwan Society of Cardiovascular Interventions

- 43 -

5月23日〈星期六〉09:00-17:00 S A T U R D A Y , M A Y 2 3 , 2 0 1 5

台北國際會議中心(TICC) 1F西側走廊

CHAIRED POSTERS (I): P01-06

Chairs: 許寬立 (Kwan-Lih Hsu)、戴任恭 (Zen-Kong Dai)、

吳彥雯 (Yen-Wen Wu)

P01 The Role of T-type Calcium Channels for Human Coronary ArterySmooth Muscle Cell Proliferation………………………………………………………曾炳憲

(Bing-Hsiean Tzeng)

P02 Higher Plasma Coenzyme Q10 Level Correlated with BetterLV Performance in AMI Patients post Primary Angioplasty………………………黃靜惠

(Ching-Hui Huang)

P03 The Utilization and Clinical Feasibility of Hand-Carry RemoteECG Recording Device in Cardiac Arrhythmias andAtrial Fibrillation: A Pilot Study…………………………………………………………洪崇烈

(Chung-Lieh Hung)

P04 Early Elevated B-type Natriuretic Peptide Levels areAssociated with Cardiac Dysfunction and Poor Clinical Outcomein Pediatric Septic Patients……………………………………………………………..徐仲豪

(Jong-Hau Hsu)

P05 The Feasibility of Percutaneous Endovascular Aortic Repair (PEVAR)for Ruptured Abdominal Aortic Aneurysm: The CGMH Experience………………武孟餘

(Meng-Yu Wu)

P06 Vitamin D Receptor Activator Paricalcitol AttenuatesIsoproterenol-induced Cardiac Fibrosis and FluorescenceExpression of CD31 and α-smooth; Smooth Muscle Actin in WKY Rats……...賴奇正

(Chi-Cheng Lai)

- 44 -

5月23日〈星期六〉09:00-17:00 S A T U R D A Y , M A Y 2 3 , 2 0 1 5

台北國際會議中心(TICC) 1F西側走廊

CHAIRED POSTERS (II): P07-12

Chairs: 陳亦仁 (Yi-Jen Chen)、莊志明 (Jyh-Ming Juang)、

楊甯貽 (Ning-I Yang)

P07 Atherosclerosis, Inflammation, and Frailty in an Elderly Population:The I-Lan Longitudinal Aging Study………………………………………………張俊欽

(Chun-Chin Chang)

P08 The Feasibility and Diagnostic Utility of Estimated Glomerular Infiltration Rate in Evaluating Peripheral Arterial Occlusive Diseases……………林岳鴻

(Yueh-Hung Lin)

P09 Impact on Prevalence and Prognosis of Brugada-TypeElectrocardiogram by 2012 ISHNE Diagnostic Criteria:A Nationwide Community-Based Study……………………………………………….陳璟毓

(Ching-Yu Chen)

P10 Differential Sodium Current Expression and Redistribution ofSodium Channels Underlie Proarrhythmic Effects of Piceatannolin Ischemia-Reperfusion Rabbit Hearts………………………………………………張伯丞

(Po-Cheng Chang)

P11 Application of Dsg2 peptide for Inhibition of Angiogenesis inAngiogenesis-related Diseases………………………………………………………盧奇聖

(Chi-Sheng Lu)

P12 Role of Left Atrial Reservoir Strain Rate in Left Atrial Remodelingin Severe Mitral Regurgitation….…………………………………………………….楊荔丹

(Li-Tan Yang)

- 45 -

5月23日(星期六)09:00-17:00 SATURDAY, MAY 23, 2015

1F, 論文壁報展示區

POSTER PRESENTATION

ELECTROPHYSIOLOGY

P13 The Detection Rate and Incidence of 24-hours Hand Carry RemoteECG Recording Device in Symptom-Driven Ventricular Arrhythmias:A Pilot Study………………………………………………………………………………洪崇烈

(Chung-Lieh Hung)

CARDIAC IMAGING

P14 The Predictive Value of RV Strain in Doxorubicin Induced Cardiotoxicityin Patients with Breast Cancer…………………………………………………………張瑋婷

(Wei-Ting Chang)

P15 Epicardial Adipose Tissue Thickness as a Useful Predictor ofCardiovascular Outcomes in Patients with Atrial Fibrillation………………………蘇河名

(Ho-Ming Su)

P16 Tissue Doppler Imaging Predicts Outcome in Hemodialysis Patientswith Preserved EF……………………………………………………………………..…黃偉銘

(Wei-Ming Huang)

P17 Clinical Significance of Right Ventricular Activity onTreadmill Tl-201 Myocardial SPECT Using CZT Cameras…………………………吳彥雯

(Yen-Chun Wu)

P18 Left Ventricular Deformation and Torsion in Asymptomatic Subjectswith Early Renal Insufficiency…………………………………………………………..宋國慈

(Kuo-Tzu Sung)

P19 The Association Between Microalbuminuria, Left Ventricular Geometryand Cardiac Mechanics in Asymptomatic Individuals………………………………宋國慈

(Kuo-Tzu Sung)

HYPERTENSION

P20 Effects of Antihypertensive Therapies on Primary and SecondaryPrevention of Stroke: Systematic Review and Network Meta-analysis…………..鄭浩民

(Hao-Min Cheng)

- 46 -

P21 The Association between Charlson Comorbidity Index, Related ClinicalDeterminants and Frequency in the Utilization of Remote BloodPressure Monitor Device from Remote Home Care System……………………….洪崇烈

(Chung-Lieh Hung)

CORONARY ARTERY DISEASE

P22 Impact of Regional Differences on Cardiovascular Outcome in PatientsUndergoing Coronary Angiography or Intervention in Acute CoronarySyndrome: A Population-based Study from NHIRD of Taiwan…………………….朱俊源

(Chun-Yuan Chu)

P23 Impact of Chronic Kidney Disease and Diabetes Mellitus on thePrognosis in Patients with Acute Myocardial Infarction…………………………….陳永崢

(Yung-Cheng Chen)

P24 Comparison of Bare-metal Stent and Drug-eluting Stent forthe Treatment of Patients Undergoing Percutaneous CoronaryIntervention for Unprotected Left Main Coronary Artery Disease-Long-term Result from a Single Center Experience………………………………...賴志泓

(Chih-Hung Lai)

P25 Effect of Team Resource Management on Quality of Care in Patientswith Acute ST-elevation Myocardial Infarction……………………………………….吳學明

(Xue-Ming Wu)

P26 Leukocytosis Independently adds Prognostic Value to the TraditionalTIMI Risk Score for ST-elevation Myocardial Infarction afterPrimary Percutaneous Coronary Intervention………………………………………..葉衍廷

(Yen-Ting Yeh)

P27 Tirofiban Associated with the Lower Mortalilty inTaiwanese STEMI Patients Undergoing Primary PCI…………………………….劉崢偉

(Cheng-Wei Liu)

P28 Shorter Pre-ejection Period in Patients with Acute MyocardialInfarction who Received Percutaneous Coronary Intervention –an Evidence of Adrenergic Stress?……………………………………………………黃繼正

(Chi-Cheng Huang)

P29 The 5A/6A Polymorphism of the Matrix Metalloproteinase3 Gene Promoter and Cardiovascular Death among Patientswith Premature Coronary Artery Disease……………………………………………..陳俊延

(Chun-Yen Chen)

- 47 -

P30 Comparison of Extended Long-term Clinical Outcomes amongZotarolimus-eluting, Sirolimus-eluting, and Paclitaxel-eluting Stentsin Chinese People……………………………………………………………………….邱俊仁

(Chiung-Zuan Chiu)

P31 The Impacts of Prolonged Emergency Department Stay onClinical Outcomes of Patients with ST-segment Elevation MyocardialInfarction after Receiving Primary Percutaneous Coronary Intervention………陳煌中

(Huang-Chung Chen)

P32 Predictors of Contrast-induced Acute Kidney Injury inPatients with ST-segment Elevation Myocardial InfarctionUndergoing Primary Percutaneous Coronary Intervention…………………………劉崢偉

(Cheng-Wei Liu)

P33 Benefits of Intraaortic Balloon Support for Myocardial Infarction Patientsin Profound Cardiogenic Shock Undergoing Coronary Revascularization……….毛畯台

(Chun-Tai Mao)

BASIC SCIENCE

P34 Paradoxical Effects of KB-R7943 on Arrhythmogenicity in aChronic Myocardial Infarction Rabbit Model…………………..…………………….張伯丞

(Po-Cheng Chang)

P35 Extracellular Superoxide Dismutases Gene Transfer Usinga Navel Baculoviral Vector………………………………………………………………林少琳

(Shoa-Lin Lin)

P36 iTRAQ Quantitative Proteomics-Based Identification ofCell Adhesion as a Dominant Phenotypic Modulationin Thrombin-Stimulated Human Aortic Endothelial Cells…………………………...王黃舟

(Huang-Joe Wang)

P37 Chinese Herbal Medicine Formula Tao-Ren-Cheng-Qi Tang Protects Stroke…張釗監(Chao-Chien Chang)

P38 High Glucose-induced Cardiomyocyte Injury is MediatedAutophagy via Matrix Metaloprotenase……………………………………………….何豐名

(Feng-Ming Ho)

P39 Autophagy Prevent Transendothelial Migration of MonocytesMediated Matrix Metalloproteinase in High Glucose……………………………...何豐名

(Feng-Ming Ho)

- 48 -

P40 Impact of Carvedilol Therapy on Protected against Myocardiumfrom Doxorubicin Damage………………………………………………………………陳永隆

(Yung-Lung Chen)

HEART FAILURE

P41 Circulating Soluble CD163 Levels are Independently Associatedwith Heart Failure…………………………………………………………………………黃啟倫

(Chi-Lun Huang)

P42 Uric acid Predicts Clinical Outcomes in Acute Heart Failure………………………黃偉銘(Wei-Ming Huang)

P43 Telemedicine and Structured Patient Support Programin Patients with Acute Myocardial Infarction and Heart Failure:a Feasibility Study in a Single Center Experience…………………………………..吳彥雯

(Yen-Chun Wu)

P44 Red Cell Distribution width and Mortality in Acute Heart Failure Patientswith Chronic Kidney Disease……………………………………………………………鄭宇倫

(Yu-Lun Cheng)

P45 Plasma B-type Natriuretic Peptide Decreasing Ratio PredictsLeft Ventricle Remodeling………………………………………………………………徐仁德

(Jen-Te Hsu)

P46 Nighttime Electromechanical Activation Time, Pulsatile Hemodynamics,and Discharge Outcomes in Patients with Acute Heart Failure……………………張俊欽

(Chun-Chin Chang)

GENERAL CARDIOLOGY

P47 The Effect of a 14-day Free Trial of Telehealth Care Program amongPatients Hospitalized for Cardiovascular Diseases onReadmission- A Propensity Score Matching Study…………………………………洪啟盛

(Chi-Sheng Hung)

P48 Gender Difference in Cardiovascular Outcome after Percutaneous CoronaryIntervention in Taiwanese Patients with Coronary Artery Disease…………….…林茂仁

(Mao-Jen Lin)

P49 The Utilization, Non-Adherence to Guidelines Rate on Measured SugarLevel by Remote Blood Sugar Monitor Device from Home Care System………..洪崇烈

(Chung-Lieh Hung)

- 49 -

P50 Newly Diagnosed Atrial Fibrillation is an Independent Factor forFuture Major Adverse Cardiovascular Events………………………………………林佳濱

(Chia-Pin Lin)

P51 Major Adverse Cardiovascular Events in Treated Periodontitis…………………周星賢(Shing-Hsien Chou)

P52 Exposure to Ambient Fine Particulate Matter is Associated withDecreased Heart Rate Variability in Patients with PreviousST Segment Elevation Myocardial Infarction (STEMI)……………………………...黃慶昌

(Ching-Chang Huang)

P53 Exposure to Ambient Fine Particulate Matter (PM2.5) Decreases Heart RateVariability (HRV) in both Linear and Monlinear Parameters in Patientswith Previous ST Segment Elevation Myocardial Infarction (STEMI)…………….黃慶昌

(Ching-Chang Huang)

P54 Management of Pericardial Effusion: 5-year Experience inPuli Christian Hospital…………………………………………………………………崔東霖

(Tung-Lin Tsui)

P55 Off-label Use of Rivaroxaban…………………………………………………………林詩晴(Shih-Ching Lin)

P56 Use of Evidence-based Medication in Patients with PTCA or CABG……………馮文翰(Wen-Han Feng)

P57 The Prognostic Impact of Maintained Sinus Rhythm on New-onsetAtrial Fibrillation in Patients with Severe Sepsis/Septic Shock……………..…….劉文正

(Wen-Cheng Liu)

P58 Comparison of Safety between Endomyocardial Biopsy Techniqueby Directly Pre-shaped Bioptome Versus Telescope(Judkin Right Catheter Protection)……………………………………………………杜宗明

(Chung-Ming Tu)

P59 The Relationship between the Synchronous Telehealth CommunicationProcess Characteristics and Care Effectiveness……………………………………李任光

(Jen-Kuang Lee)

P60 Gender Differences in Major Adverse Cardiovascular Outcomesamong Older Patients with Atherothrombotic Diseases:A Population-based Longitudinal Study in Taiwan…………………………………李文賢

(Wen-Hsien Lee)

- 50 -

P61 Willing for Telehealth Care Use in Patients with Coronary Artery Disease……李任光(Jen-Kuang Lee)

P62 Type A Acute Aortic Dissection In the Younger Patients…………………………..鄭全皓(Quan-Hau Cheng)

P63 Improved Hyponatremia after Pericardial Drainage inPatients Suffering from Cardiac Tamponade…………………………………………鍾伯欣

(Bor-Hsin Jong)

P64 Efficacy and Safety of Atorvastatin 80mg……………………………………………林宗憲(Tsung-Hsien Lin)

P65 Cardiovascular Outcomes of Sitagliptin in Type 2Diabetic Patients with Acute Myocardial Infarction,A Population-Based Cohort Study in Taiwan……………………………………陳天心

(Tien-Hsing Chen)

- 51 -

5月22日〈星期五〉18:30-20:30 FRIDAY, MAY 22, 2015

台北國際會議中心(TICC) 4F, VIP Room, TICC

SATELLITE SYMPOSIUM: CROSS-STRAIT THROMBOSIS FORUM

18:30 Opening Remarks……………………………….……….….……….……..程文俊、黃德嘉(Wen-Jin Cherng & Dejia Huang)

Chair: 黃德嘉 (Dejia Huang)

18:35 Individualized DAPT Practice from Results of DAPT Trial.…….…………...……王　炎(Yan Wang)

19:00 One Year Result of OPT-CAD Registry in China………………..……….…….……周穎玲(Yingling Zhou)

Chair: 殷偉賢 (Wei-Hsian Yin)

19:25 Taiwan ACS Management: From ACS-FS Registry to STENT Registry…………邱昱偉(Yu-Wei Chiu)

19:50 STENT Registry Subgroup Analysis ─ Effect of Statin……………………….…王宇澄(Yu-Chen Wang)

20:05 STENT Registry Subgroup Analysis ─ CKD Population……….………….……謝明哲(Ming-Jer Hsieh)

Chairs: 黃德嘉、陳志鴻 (Dejia Huang & Jyh-Hong Chen)

20:20 Q&A.…………………...…………………………………………………………..………..……All

20:25 Closing Remarks…………………….……………………….………..……黃德嘉、陳志鴻(Dejia Huang & Jyh-Hong Chen)

- 52 -



SATELLITE SYMPOSIUM: THINK DIFFERENT ON BP CONTROL ANDLIPID MANAGEMENT : TO REDUCE MORE CV EVENTS, AND

MAXIMIZE THE BENEFITS

12:15 Opening Remarks……………………………………………….….…….………..…….王國陽(Kuo-Yang Wang)

12:20 After HPS2-THRIVE and IMPROVE-IT Trials, How can We MaximizeCV Events Reduction in 2015? Focus on Lipid Treatment.…….…………….……林宗憲

(Tsung-Hsien Lin)

12:45 Beyond BP control, can We Reduce more Risks for more Patients?...……..……王俊傑(Chun-Chieh Wang)

13:10 Panel Discussion.………………………………………………………...………………..……All

13:25 Closing Remarks……………………………………………….…………………………王國陽(Kuo-Yang Wang)

- 53 -



SATELLITE SYMPOSIUM: STROKE PREVENTION IN ATRIALFIBRILLATION ─ BETTER STRATEGIES, BETTER OUTCOMES

12:15 Opening Remarks…………………………………………….….……….………..…….邱春旺(Chuen-Wang Chiou)

Chair: 邱春旺 (Chuen-Wang Chiou)

12:20 Optimizing Stroke Prevention in Atrial Fibrillation: What’s New?……..…Gregory YH Lip

13:00 Practical Consideration for Stroke Prevention in Atrial Fibrillation:Choosing the Right Drug for Right Patients………………………………….…. …..江晨恩

(Chern-En Chiang)


13:30 Panel Discussion.…………………………………………………………...……………..……All

13:40 Closing Remarks……………………………………………….…………………………陳志鴻(Jyh-Hong Chen)

- 54 -



SATELLITE SYMPOSIUM: CRUSADE TO HYPERTENSION ─ CATCHUP THE TREND FOR HYPERTENSION MANAGEMENT

12:15 Opening Remarks……………………………………………….………..………..…….洪大川(Ta-Chuan Hung)

Chair: 洪大川 (Ta-Chuan Hung)

12:20 NICE Guidelines Approach to Control Blood Pressure…….….……..…….Bryan Williams

- Rationale for Treatment Strategy- Factor Organ Protection in Patients with HT

12:55 2015 TSOC/THS Hypertension Guidelines……….………………………..…..…….翁國昌(Kwo-Chang Ueng)

- What’s New or Different in the Guidelines- Risk Factors Management in Patients with AF

13:25 Q&A………………………………………………………………………………………..………All

13:40 Wrap Up and Closing Remarks…………………………………………………...……殷偉賢(Wei-Hsian Yin)

- 55 -



SATELLITE SYMPOSIUM: ARB AND DPP4i ACROSS THE CVCONTINUUM

17:30 Opening Remarks…………………….………………………….……….………..…….許惠恆(Wayne Huey-Herng Sheu)

Chair: 許惠恆 (Wayne Huey-Herng Sheu)

17:35 Clinical Insights from the EXAMINE Trial: A Major Study ofCardiovascular Outcomes in Type 2 Diabetes Mellitus………..…..…….William B. White

18:10 Why Azilsartan-M is the “Gold Standard” Treatment forHypertension?.....................................................................................William B. White

18:45 Experts Discussion………………………………………….………..……林俊立、邱春旺(Jiunn-Lee Lin & Chuen-Wang Chiou)

18:55 Closing Remarks……………………….…………………………………………...……陳文鍾(Wen-Jone Chen)

- 56 -



SATELLITE SYMPOSIUM: BUILDING BLOCKS IN PURSUIT OFBETTER CONTROL IN ACS INTERVENTION

17:30 Opening Remarks……………………………………………….……….….……..…….陳肇文(Jaw-Wen Chen)

Chair: 陳肇文 (Jaw-Wen Chen)

17:35 Building Blocks in Pursuit of Better Control in ACS Intervention………….…..Hideki Ishii(石井秀樹)

Chair: 方慶章 (Ching-Chang Fang)

18:35 Panel Discussion.……………………………………………………………...…………..……All

18:55 Closing Remarks……………………………………………….…………………………黃瑞仁(Juey-Jen Hwang)

- 57 -



SATELLITE SYMPOSIUM: 2015 ATRIAL FIBRILLATIONREVOLUTION

17:30 Opening Remarks……………………………………………….……….…….…..…….賴文德(Wen-Ter Lai)

Chair: 劉言彬 (Yen-Bin Liu)

17:35 Role of Stroke and Stroke Prevention in Atrial FibrillationAsians vs. Non-Asians……………………..…………………………..………………..趙子凡

(Tze-Fan Chao)

Chair: 王俊傑 (Chun-Chieh Wang)

18:00 Atrial Fibrillation Management in Stroke and CKD………...........…......…Gregory YH Lip

Chairs: 王俊傑 (Chun-Chieh Wang)、劉言彬 (Yen-Bin Liu)

18:35 Panel Discussion.…………………………………………………………………...……..……All

18:55 Closing Remarks……………………………………………….…………………………王俊傑(Chun-Chieh Wang)

- 58 -



SATELLITE SYMPOSIUM: CRACKING THE ENIGMA OF METABOLICAND CARDIOVASCULAR CONTINUUM

17:30 Opening Remarks………………………………………………..……….………..…….程俊傑(Jun-Jack Cheng)


17:35 Duration of DAPT: What’s the Right Way to go?…………………………….….…..李貽恆(Yi-Heng Li)


18:05 Glycemic Control in Patients with CV Disease……………………………….….…..江晨恩(Chern-En Chiang)

18:35 Panel Discussion.……………………………………………………….………………………All

18:55 Closing Remarks……………………………………………….…………………………林幸榮(Shing-Jong Lin)

- 59 -



SATELLITE SYMPOSIUM: LIFETIME BENEFIT OF LOWERING LDL-C─ EVIDENCE FROM CV OUTCOME TRIALS FOR COMBINATION

APPROACH

17:30 Opening Remarks………………………………………………..……….………..…….陳宗瀛(Chung-Yin Chen)

Chair: 陳宗瀛 (Chung-Yin Chen)

17:40 Lowering CV Risk ─ Can We Improve It?…………………………….…..Karam Kostner

18:20 Panel Discussion.…………………………………………………………….…………………All

18:50 Closing Remarks……………………………………………….…………………………陳宗瀛(Chung-Yin Chen)

- 60 -

5月24日〈星期日〉12:40-14:10 SUNDAY, MAY 24, 2015


SATELLITE SYMPOSIUM: MOVE ON TO THE NEXT STAGE WITHEDOXABAN

12:40 Opening Remarks……………………………………………….……….………..…….葉森洲(San-Jou Yeh)

Chair: 葉森洲 (San-Jou Yeh)

12:45 ENGAGE-AF TIMI 48…………………………………………………………………Atul Verma

- Main Outcome- Key Subanalyses

Chair: 葉森洲 (San-Jou Yeh)

13:00 How can We ENGAGE Asians?…….………………….….………………………..…江晨恩(Chern-En Chiang)

Chair: 陳適安 (Shih-Ann Chen)

13:30 Panel Discussion.………………………………………………………………………….……All

13:40 Closing Remarks……………………………………………….…………………………陳適安(Shih-Ann Chen)

- 61 -

5月24日〈星期日〉12:40-14:10 SUNDAY, MAY 24, 2015


SATELLITE SYMPOSIUM: ERA OF NOAC-LEADING EXCELLENCE INVENOUS ARTERIAL THROMBOSIS MANAGEMENT

12:40 Opening Remarks……………………………………………….……….………..…….葉宏一(Hung-I Yeh)

Chair: 葉宏一 (Hung-I Yeh)

12:45 Decision Making for Anticoagulation in AF: Combining Global andAsian Studies to Clinical Practices……..…………..………………………Tetsuya Matoba

Chair: 褚柏顯 (Pao-Hsien Chu)

13:15 TSOC DVT Management Consensus ─How to Integrade into Daily Practice?……………….……………………………..…張維典

(Wei-Tien Chang)

Chairs: 葉宏一 (Hung-I Yeh)、褚柏顯 (Pao-Hsien Chu)

13:45 Panel Discussion.………………………………………………………...………………..……All

14:05 Closing Remarks……………………………………………….…………………………褚柏顯(Pao-Hsien Chu)

- 62 -

5月24日〈星期日〉12:40-14:10 SUNDAY, MAY 24, 2015

台北國際會議中心(TICC) Room 201BC

SATELLITE SYMPOSIUM: ANTIPLATELET AND LIPID-LOWERINGTHERAPIES FOR THE SECONDARY PREVENTION OF

CARDIOVASCULAR DISEASE-ARE WE DOING ENOUGH?

12:40 Opening Remarks……………………………………………….…….….………..…….黃瑞仁(Juey-Jen Hwang)

Chair: 黃瑞仁 (Juey-Jen Hwang)

12:45 East Asian Paradox: Shall We Be All the Same asWhite Population in Antiplatelet Therapy?………………………………………...…趙庭興

(Ting-Hsing Chao)

Chair: 洪志凌 (Chi-Ling Hang)

13:05 Optimizing Duration of Antiplatelet Therapy Following PCI ─For Whom and How Long?……………………………….……….………………....…邱俊仁

(Chiung-Zuan Chiu)


13:25 PCSK9 Inhibitors Poised for Breakthrough asNew Cholesterol-lowering Therapy…………………….…..…….…………….…..…林宗憲

(Tsung-Hsien Lin)


13:45 Panel Discussion.…………………………………………………………………...……..……All

14:05 Closing Remarks……………………………………………….………….……………李文領(Wen-Lieng Lee)

tsoc tsoc annual...- 3 - 5ꓫ23ꓩꅱ걐듁꒻ꅲ08:45-10:15 saturday, may 23, 2015...

Documents